Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?

To: Scott H. Davis who wrote (890)	11/10/1998 9:05:00 PM
From: William Strop	Respond to of 1972

So what do you think the Chiron increased competition is??? Not that this can't happen but I don't think any of these companies are far enough along with their respective gene tharapy products for 'analysts' to make an informed statement regarding competition. Their target of $32, or $24 or Murphy's target for 1996 of $100 are all pretty much picked out of the air... imo anyway. Bill